Facebook Twitter

Osmotics Corp. enters licensing accord with BYU

SHARE Osmotics Corp. enters licensing accord with BYU

Denver-based pharmaceutical company Osmotics Corp. has entered into a worldwide exclusive licensing agreement with Brigham Young University to acquire rights to a group of patented compounds, cationic steroid antibiotics, and methods for treating antibiotic-resistant bacterial infections.

Terms were not disclosed.

The licensed technology is based on the research of Paul B. Savage, a BYU chemistry professor.